日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The breast cancer risk assessment pathway in England: a systems analysis of current challenges and ways to improve

英格兰乳腺癌风险评估路径:当前挑战及改进途径的系统分析

Valasaki, Maria; Taylor, Lily C; Woof, Victoria G; Howell, Sacha J; Tischkowitz, Marc; Antoniou, Antonis C; Archer, Stephanie; French, David P; Usher-Smith, Juliet A

Prognostic performance of thymidine kinase 1 activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with CDK4/6 and aromatase inhibitors

胸苷激酶1活性在接受CDK4/6和芳香化酶抑制剂治疗的激素受体阳性、HER2阴性转移性乳腺癌患者中的预后性能

Brown, Nicole L; Howell, Sacha J; Papantoniou, Dimitrios; Eriksson, Olle; Bergqvist, Mattias; Williams, Amy; Kavanagh, Amy; Backlund, Alexandra; Albu-Kareem, Ahmed; Elinder, Ellinor; Larsson, Karolina; Uminska, Monika; Ekholm, Maria

Acceptability of breast cancer risk assessment amongst general population women aged 30-39 years: A qualitative study

30-39岁普通女性对乳腺癌风险评估的接受度:一项定性研究

Horton, Rosie; Hindmarch, Sarah; Howell, Sacha J; Usher-Smith, Juliet A; Gorman, Louise; Evans, D Gareth; French, David P

Understanding the preferences of younger women for the delivery of a service to predict breast cancer risk: a discrete choice experiment

了解年轻女性对乳腺癌风险预测服务提供的偏好:一项离散选择实验

Wright, Stuart J; Thapa, Shabnam; Salisbury, Amber; Hindmarch, Sarah; French, David P; Howell, Sacha J; Payne, Katherine

Anti-progestin therapy targets hallmarks of breast cancer risk.

抗孕激素疗法针对乳腺癌风险的标志性特征。

Simões Bruno M, Pedley Robert, McCloskey Curtis W, Roberts Matthew, Reed Austin D, Twigger Alecia-Jane, Tharmapalan Pirashaanthy, Caruso Amanda, Cabral Sara, Wilby Anthony J, Harrison Hannah, Zhou Yuxi, Greenhalgh Alice, Alghamdi Suad A, Forestiero Martina, Lopez-Muñoz Jesica, Roche Jasmin, Tuieng Ren Jie, Khan Muhammad A, Squires Steven, Astley Susan M, Harkness Elaine F, Santiago-Gómez Angélica, Spence Katherine, Ritchie Jessica, Pritchard Susan, Lim Yit, Sherratt Michael J, Andò Sebastiano, Howell Anthony, Evans D Gareth, Gilmore Andrew P, Khaled Walid T, Khokha Rama, Clarke Robert B, Howell Sacha J

Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib

作者更正:CDK7抑制剂samuraciclib I期研究中晚期乳腺癌患者的剂量递增和扩展队列

Coombes, R C; Howell, Sacha; Lord, Simon R; Kenny, Laura; Mansi, Janine; Mitri, Zahi; Palmieri, Carlo; Chap, Linnea I; Richards, Paul; Gradishar, William; Sardesai, Sagar; Melear, Jason; O'Shaughnessy, Joyce; Ward, Patrick; Chalasani, Pavani; Arkenau, Tobias; Baird, Richard D; Jeselsohn, Rinath; Ali, Simak; Clack, Glen; Bahl, Ashwani; McIntosh, Stuart; Krebs, Matthew G

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification

对超过40万名女性的分析为BRCA1和BRCA2变异分类提供了病例对照证据。

Zanti, Maria; O'Mahony, Denise G; Parsons, Michael T; Dorling, Leila; Dennis, Joe; Boddicker, Nicholas J; Chen, Wenan; Hu, Chunling; Naven, Marc; Yiangou, Kristia; Ahearn, Thomas U; Ambrosone, Christine B; Andrulis, Irene L; Antoniou, Antonis C; Auer, Paul L; Baynes, Caroline; Bodelon, Clara; Bogdanova, Natalia V; Bojesen, Stig E; Bolla, Manjeet K; Brantley, Kristen D; Camp, Nicola J; Campbell, Archie; Castelao, Jose E; Cessna, Melissa H; Chang-Claude, Jenny; Chen, Fei; Chenevix-Trench, Georgia; Conroy, Don M; Czene, Kamila; De Nicolo, Arcangela; Domchek, Susan M; Dörk, Thilo; Dunning, Alison M; Eliassen, A Heather; Evans, D Gareth; Fasching, Peter A; Figueroa, Jonine D; Flyger, Henrik; Gago-Dominguez, Manuela; García-Closas, Montserrat; Glendon, Gord; González-Neira, Anna; Grassmann, Felix; Hadjisavvas, Andreas; Haiman, Christopher A; Hamann, Ute; Hart, Steven N; Hartman, Mikael B A; Ho, Weang-Kee; Hodge, James M; Hoppe, Reiner; Howell, Sacha J; Jakubowska, Anna; Khusnutdinova, Elza K; Ko, Yon-Dschun; Kraft, Peter; Kristensen, Vessela N; Lacey, James V; Li, Jingmei; Lim, Geok Hoon; Lindström, Sara; Lophatananon, Artitaya; Luccarini, Craig; Mannermaa, Arto; Martinez, Maria Elena; Mavroudis, Dimitrios; Milne, Roger L; Muir, Kenneth; Nathanson, Katherine L; Nuñez-Torres, Rocio; Obi, Nadia; Olson, Janet E; Palmer, Julie R; Panayiotidis, Mihalis I; Patel, Alpa V; Pharoah, Paul D P; Polley, Eric C; Rashid, Muhammad U; Ruddy, Kathryn J; Saloustros, Emmanouil; Sawyer, Elinor J; Schmidt, Marjanka K; Southey, Melissa C; Tan, Veronique Kiak-Mien; Teo, Soo Hwang; Teras, Lauren R; Torres, Diana; Trentham-Dietz, Amy; Truong, Thérèse; Vachon, Celine M; Wang, Qin; Weitzel, Jeffrey N; Yadav, Siddhartha; Yao, Song; Zirpoli, Gary R; Cline, Melissa S; Devilee, Peter; Tavtigian, Sean V; Goldgar, David E; Couch, Fergus J; Easton, Douglas F; Spurdle, Amanda B; Michailidou, Kyriaki

Randomised phase-2 screening trial of intermittent energy restriction plus resistance exercise versus resistance exercise alone during chemotherapy for advanced breast cancer

一项随机二期筛选试验,比较间歇性能量限制联合阻力训练与单纯阻力训练在晚期乳腺癌化疗期间的疗效

Harvie, Michelle; Pegington, Mary; Howell, Anthony; Lim, Yit; Livingstone, Karen; Rose, Danielle; McMullan, Debbie; Maxwell, Anthony; Barrett, Emma; Sellers, Katharine; Krizak, Suzanne; Howell, Sacha J

Integration of personalised ultrasensitive ctDNA monitoring of patients with metastatic breast cancer to reduce imaging requirements

将个性化超灵敏ctDNA监测应用于转移性乳腺癌患者,以减少影像检查需求。

Mouhanna, Pia; Ståhlberg, Anders; Andersson, Daniel; Albu-Kareem, Ahmed; Elinder, Ellinor; Eriksson, Olle; Kavanagh, Amy; Kovács, Anikó; Larsson, Karolina F; Linderholm, Barbro; Uminska, Monika; Österlund, Tobias; Howell, Sacha J; Ekholm, Maria

Capivasertib and fulvestrant for patients with HR-positive/HER2-negative advanced breast cancer: analysis of the subgroup of patients from Japan in the phase 3 CAPItello-291 trial

Capivasertib 和 fulvestrant 用于 HR 阳性/HER2 阴性晚期乳腺癌患者:CAPItello-291 III 期试验中日本患者亚组分析

Tokunaga, Eriko; Iwata, Hiroji; Itoh, Mitsuya; Taira, Tetsuhiko; Toyama, Tatsuya; Mizuno, Toshiro; Osaki, Akihiko; Yanagita, Yasuhiro; Nakamura, Seigo; Nakamura, Rikiya; Sambe, Tomoko; Ozaki, Toshiaki; Schiavon, Gaia; Howell, Sacha J; Toi, Masakazu